IPP Bureau
UFlex-Asepto to set up India’s first U-shaped paper straw line for aseptic liquid cartons
By IPP Bureau - April 19, 2022
New product line to address the challenge of restrictions on use of plastic straws
Intas Pharmaceuticals and Comera Life Sciences announce research collaboration
By IPP Bureau - April 19, 2022
Under the terms of the partnership agreement, Comera will develop a differentiated formulation of an Intas product using Comera's innovative proprietary SQore formulation platform
AI driven Israeli company Embryonics ties-up with Jaslok Hospital
By IPP Bureau - April 19, 2022
The data driven fertility company helps increase the success rate of fertility treatments
Akron Bio completes plasmid DNA manufacturing facility
By IPP Bureau - April 19, 2022
The facility will support clinical development by securing supply that will address the critical demand in the gene therapy and vaccine markets
PM Narendra Modi lays down five goals for new WHO Global Centre
By IPP Bureau - April 19, 2022
Jamnagar’s contributions towards wellness will get a global identity with WHO’s Global Centre for Traditional Medicine
E-learning in diabetes management for nurses launched
By IPP Bureau - April 19, 2022
India-Sweden Healthcare Innovation Centre in collaboration with AIIMS Jodhpur and AstraZeneca India launches an e-learning Upskilling Program in Diabetes Management for nurses
SonoScape receives USFDA 510(k) clearance for HD-550 Endoscopy system
By IPP Bureau - April 18, 2022
The HD-550 endoscopy system has been available outside of the USA since 2019
Albumedix and Valneva expand collaboration to include newly approved inactivated Covid-19 vaccine
By IPP Bureau - April 18, 2022
This marks an expansion of the companies' existing collaboration and further validates the use of Albumedix Recombumin rHA products in the manufacturing process and final formulation of critical vaccines
Amneal achieves second U.S. biosimilars approval with Alymsys
By IPP Bureau - April 18, 2022
Marks the second of three biosimilars Amneal expects to receive U.S. approval for in 2022
GSK to acquire Sierra Oncology for US $1.9bn
By IPP Bureau - April 18, 2022
Momelotinib complements GSK’s existing expertise in haematology, with Sierra Oncology anticipating US regulatory submission in Q2 this year and EU submission in the second half of 2022
Geocann and Averix Bio to partner on API phytocannabinoid ingredients
By IPP Bureau - April 18, 2022
This partnership allows both companies to become first movers to bridge an inevitable gap with the largest organizations in the pharmaceutical, nutraceutical, cosmetic, and veterinary sectors
Sanofi India appoints Rodolfo Hrosz as new Managing Director
By IPP Bureau - April 18, 2022
Rodolfo brings with him a wealth of rich experience from commercial, marketing, and general management roles across several multinational companies
Fujifilm India completes installation of 50,000 medical devices in India
By IPP Bureau - April 18, 2022
Fujifilm’s NEVER STOP philosophy to enhance the access to healthcare for all Indians
Ministry of Health and Family Welfare (MoHFW) organises Health Mela
By IPP Bureau - April 18, 2022
These melas serve as platforms to attract thousands of people to avail quality healthcare services along with essential medicines and diagnostic services
Lupin receives tentative approval from USFDA for Tenofovir Alafenamide Tablets
By IPP Bureau - April 18, 2022
This product will be manufactured at Lupin’s Nagpur facility in India
